Lv11
10 积分 2026-11-13 加入
Oral Presentations（Long term safety outcomes with inebilizumab treatment in neuromyelitis optica spectrum disorder: the N-MOmentum trial）
1小时前
求助中
Emerging drugs for the treatment of neuromyelitis optica
1天前
已完结
Disseminated gonococcal infection developing two days after initial eculizumab administration in a patient with neuromyelitis optica spectrum disorder: A case report and literature review
1天前
已完结
Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects
1天前
已完结
Risk of hepatitis B and tuberculosis reactivation in patients with neuromyelitis optica spectrum disorder undergoing B cell depletion therapy
2天前
已完结
皖公网安备34019202002308
